114. Non-dystrophic myotonia syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 13 / Drugs : 17 - (DrugBank : 3) / Drug target genes : 6 - Drug target pathways : 5
| Other names | Non-dystrophic Myotonia;Myotonia congenita;Thomsen disease;Thomsen syndrome;Autosomal-dominant myotonia congenita;Becker disease;Becker syndrome;Autosomal-recessive myotonia congenita;Paramyotonia congenita;Sodium channel myotonia; | ||
|---|---|---|---|
| Disease group | Neuromuscular diseases | ||
|
Domestic patients
Med expenses recipients, FY2024 (corrected) (in Japanese) |
34 patients Age distribution
|
||
| Clinical research form (in Japanese) MHLW Intractable Diseases, FY2026 (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 11-22-55. Non-dystrophic myotonia | ||
| Sub-diseases (Clinical research forms may not be available for all sub-diseases.) | - | ||
